Scales Corporation Limited (NZE:SCL)
New Zealand
· Delayed Price · Currency is NZD | Market Cap | 873.01M |
| Revenue (ttm) | 899.95M |
| Net Income (ttm) | 100.99M |
| Shares Out | 145.02M |
| EPS (ttm) | 0.70 |
| PE Ratio | 8.58 |
| Forward PE | 15.84 |
| Dividend | 0.30 (4.99%) |
| Ex-Dividend Date | Jan 12, 2026 |
| Volume | 96,574 |
| Average Volume | 102,958 |
| Open | 6.07 |
| Previous Close | 6.01 |
| Day's Range | 5.96 - 6.17 |
| 52-Week Range | 4.02 - 6.41 |
| Beta | 0.22 |
| RSI | 49.39 |
| Earnings Date | Feb 24, 2026 |
About Scales Corporation
Scales Corporation Limited engages in manufacturing and trading of food ingredients in New Zealand, Asia, Europe, North America, and internationally. It operates through Global Proteins, Horticulture, Logistics, and Other segments. The company processes and markets proteins, such as pet food ingredients, edible meat, and offal products; and orchards, fruit packing, and juice concentrate. In addition, it provides sea and air freight, and logistics services. Further, the company provides insurance services; and operates cold storage. Scales Corpo... [Read more]
Financial Performance
In 2025, Scales Corporation's revenue was 899.95 million, an increase of 53.94% compared to the previous year's 584.63 million. Earnings were 100.99 million, an increase of 232.89%.
Financial StatementsNews
Scales Corporation Transcript: AGM 2026
Record financial results were achieved across all divisions, with strong growth in revenue and profit. The board saw key changes, new executive appointments, and an increased director remuneration pool. Strategic investments and sustainability initiatives were highlighted, and all resolutions were supported by shareholders.
Scales Corp Ltd (HAM:S05) Full Year 2025 Earnings Call Highlights: Record Growth and Strategic ...
Scales Corp Ltd (HAM:S05) Full Year 2025 Earnings Call Highlights: Record Growth and Strategic Investments Propel Performance
Full Year 2025 Scales Corporation Ltd Earnings Call Transcript
Full Year 2025 Scales Corporation Ltd Earnings Call Transcript
Scales Corporation Earnings Call Transcript: H2 2025
Record FY 2025 results with 54% revenue growth and over 200% NPAT increase, driven by strong performances in horticulture, Global Proteins, and Logistics. FY 2026 guidance anticipates normalization in horticulture yields but continued positive momentum in all divisions.
Scales Corporation Earnings Call Transcript: H1 2025
First half 2025 saw strong growth in EBITDA and NPAT, led by horticulture and logistics, prompting an upgrade in full-year earnings guidance. Strategic investments and new facilities are driving performance, while risks from tariffs and slower pet food demand are being managed.
Scales Corporation Transcript: AGM 2025
Record financial results were achieved, with strong growth in profit and revenue, a higher dividend, and successful strategic investments. The board addressed governance, succession, and risk management, while shareholders approved all resolutions and discussed key risks and opportunities.
Scales Corp Ltd (FRA:S05) Full Year 2025 Earnings Call Highlights: Record Performance and ...
Scales Corp Ltd (FRA:S05) Full Year 2025 Earnings Call Highlights: Record Performance and Strategic Growth
Full Year 2025 Scales Corporation Ltd Earnings Call Transcript
Full Year 2025 Scales Corporation Ltd Earnings Call Transcript
Scales Corporation Earnings Call Transcript: H2 2024
Record FY2024 results with underlying EBITDA of NZD 91.7M and NPAT of NZD 53.6M, driven by strong performance across all divisions. FY2025 guidance targets NZD 35–40M NPAT, with continued growth in premium apples and Global Proteins, and stable capital management.
Scales Corporation Transcript: AGM 2024
The meeting highlighted strong underlying profit, a stable dividend, and strategic acquisitions to boost premium apple varieties and protein division growth. Board changes and climate initiatives were discussed, with shareholders approving all resolutions.
Scales Corporation Earnings Call Transcript: H1 2024
Earnings rebounded strongly in the first half of 2024, with underlying NPAT up 97% and EBITDA up 46% year-over-year. Horticulture and Logistics saw significant gains, while Global Proteins remained stable. FY 2024 guidance is reaffirmed, with ongoing supply chain risks noted.